At SkyCell, our vision is to achieve zero product loss and net-zero CO₂ emissions across the pharma industry. We have set near-term Scope 1 and 2 targets validated by the Science Based Targets initiative (SBTi), alongside long-term reduction goals and a roadmap to reach net-zero emissions across our entire supply chain by 2040. 

Focusing on climate, circularity, and cooperation, we maximize impact while cutting waste and emissions—paving the way for a more sustainable future for all.